Involvement of melatonin in autophagy-mediated mouse hepatoma H22 cell survival - PubMed (original) (raw)

Involvement of melatonin in autophagy-mediated mouse hepatoma H22 cell survival

Chang Liu et al. Int Immunopharmacol. 2012 Feb.

Abstract

The role of autophagy in cancer is controversial. Melatonin has been linked to several aspects of cancer progression and also to regulation of autophagy. Whether melatonin is involved in an autophagy-induced tumor suppressor mechanism or a cyto-protective mechanism is unknown. Therefore, we investigated the effects of melatonin on autophagy and its upstream regulator. We found that melatonin triggers an autophagic process by enhancing Beclin 1 expression and inducing a conversion of microtubule-associated protein 1 light chain 3(LC3)-I to LC3-II, the protein associated with the autophagosome membrane, in hepatoma H22 tumor-bearing mice. Moreover, melatonin inhibits the phosphorylation of the mammalian target of the rapamycin (mTOR) and Akt. Knockdown of Beclin 1 by either RNA interference or co-treatment with the autophagy inhibitor, 3-methyladenine(3-MA), significantly enhanced the melatonin-induced apoptosis in mouse hepatoma H22 cells. Our data provides the first evidence that melatonin induces protective autophagy that prevents mouse hepatoma H22 cells from undergoing apoptosis. A combination of melatonin with an autophagy inhibitor might be a useful therapeutic strategy for hepatocellular carcinoma.

Copyright © 2012 Elsevier B.V. All rights reserved.

PubMed Disclaimer

Similar articles

• Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells.
  Wang KF, Yang H, Jiang WQ, Li S, Cai YC. Wang KF, et al. Int J Mol Med. 2015 Dec;36(6):1556-62. doi: 10.3892/ijmm.2015.2378. Epub 2015 Oct 16. Int J Mol Med. 2015. PMID: 26499488 Free PMC article.
• Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
  Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC. Zhang DM, et al. Carcinogenesis. 2013 Jun;34(6):1331-42. doi: 10.1093/carcin/bgt060. Epub 2013 Feb 7. Carcinogenesis. 2013. PMID: 23393227
• The combination of RAD001 and MK-2206 exerts synergistic cytotoxic effects against PTEN mutant gastric cancer cells: involvement of MAPK-dependent autophagic, but not apoptotic cell death pathway.
  Ji D, Zhang Z, Cheng L, Chang J, Wang S, Zheng B, Zheng R, Sun Z, Wang C, Zhang Z, Liu R, Zhang X, Liu X, Wang X, Li J. Ji D, et al. PLoS One. 2014 Jan 9;9(1):e85116. doi: 10.1371/journal.pone.0085116. eCollection 2014. PLoS One. 2014. PMID: 24416349 Free PMC article.
• Teaching the basics of autophagy and mitophagy to redox biologists--mechanisms and experimental approaches.
  Zhang J. Zhang J. Redox Biol. 2015;4:242-59. doi: 10.1016/j.redox.2015.01.003. Epub 2015 Jan 13. Redox Biol. 2015. PMID: 25618581 Free PMC article. Review.
• Regulation of Cell Death Mechanisms by Melatonin: Implications in Cancer Therapy.
  Wang Z, Liu Y, Musa AE. Wang Z, et al. Anticancer Agents Med Chem. 2022;22(11):2080-2090. doi: 10.2174/1871520621999211108090712. Anticancer Agents Med Chem. 2022. PMID: 34749627 Review.

Cited by

• Interactions of melatonin with various signaling pathways: implications for cancer therapy.
  Mihanfar A, Yousefi B, Azizzadeh B, Majidinia M. Mihanfar A, et al. Cancer Cell Int. 2022 Dec 29;22(1):420. doi: 10.1186/s12935-022-02825-2. Cancer Cell Int. 2022. PMID: 36581900 Free PMC article. Review.
• Role and Therapeutic Potential of Melatonin in Various Type of Cancers.
  Gurunathan S, Qasim M, Kang MH, Kim JH. Gurunathan S, et al. Onco Targets Ther. 2021 Mar 18;14:2019-2052. doi: 10.2147/OTT.S298512. eCollection 2021. Onco Targets Ther. 2021. PMID: 33776451 Free PMC article. Review.
• Melatonin Attenuates Her-2, p38 MAPK, p-AKT, and mTOR Levels in Ovarian Carcinoma of Ethanol-Preferring Rats.
  Ferreira GM, Martinez M, Camargo IC, Domeniconi RF, Martinez FE, Chuffa LG. Ferreira GM, et al. J Cancer. 2014 Oct 3;5(9):728-35. doi: 10.7150/jca.10196. eCollection 2014. J Cancer. 2014. PMID: 25368672 Free PMC article.
• Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments.
  González A, Alonso-González C, González-González A, Menéndez-Menéndez J, Cos S, Martínez-Campa C. González A, et al. Cancers (Basel). 2021 Jun 29;13(13):3263. doi: 10.3390/cancers13133263. Cancers (Basel). 2021. PMID: 34209857 Free PMC article. Review.
• An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress.
  Mehrzadi S, Pourhanifeh MH, Mirzaei A, Moradian F, Hosseinzadeh A. Mehrzadi S, et al. Cancer Cell Int. 2021 Mar 31;21(1):188. doi: 10.1186/s12935-021-01892-1. Cancer Cell Int. 2021. PMID: 33789681 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal